Trauma News and Research

RSS

DFG to establish new Research Units

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing four new Research Units to facilitate cross-regional, interdisciplinary cooperation among researchers. This decision was taken by the DFG Senate at its autumn meeting in Bonn. The new groups are intended to enable researchers to devote themselves to current and urgent issues within their fields and to develop new approaches.

15 Oct 2010

Prolong Pharmaceuticals receives $30 million from private investor group

Prolong Pharmaceuticals today announced that the company has received a commitment of $30 million in funding from a private investor group. The monies will be dedicated to the company's continuing research and development efforts and clinical programs targeting anemias resulting from oxygen deficiency.

15 Oct 2010

Allure Medical Spa to offer FDA approved Coolsculpting by Zeltiq for non-invasive fat reduction

Great news for men and women dealing with exercise and diet-resistant fat in areas like the tummy, love handles and back rolls! Allure Medical Spa of Shelby Township is the first in Southeastern Michigan to offer Coolsculpting by Zeltiq, the first ever procedure approved by the U.S. Food and Drug Administration (Sept. 8, 2010), for the non-invasive reduction of fat. Coolsculpting by Zeltiq is a virtually painless procedure that reduces fat cells with no needles, surgery or downtime.

15 Oct 2010

GSA and NAM select journalists for new MetLife Foundation Journalists in Aging Fellows Program

The Gerontological Society of America (GSA) and New America Media (NAM) have selected 15 journalists for the new MetLife Foundation Journalists in Aging Fellows Program. They represent a wide range of traditional, new, and ethnic media, such as USA Today, Sing Tao Daily, the Minneapolis Star Tribune, and TheAtlantic.com.

14 Oct 2010

U.S. Bone and Joint Decade observes National Action Week

An annual global event, Bone and Joint National Action Week is held October 12-20 with activities focused on disorders including arthritis, back pain, osteoporosis, and the effects of childhood obesity on the musculoskeletal system. Events and projects organized worldwide are designed to raise awareness of prevention, disease management and treatments. In the United States, the U.S. Bone and Joint Decade represents the global initiative.

14 Oct 2010

Study finds hemostatic powder effective in treating 95% of patients with bleeding peptic ulcers

A new material similar to that used by the U.S. Military to treat traumatic injuries is showing promise as the next novel treatment for bleeding ulcers, a condition that commonly affects up to 15 per cent of adults, according to Hong Kong physician Dr. James Lau.

14 Oct 2010

Stony Brook professor receives 2010 NIH Director's New Innovator Award

Balaji Sitharaman, Ph.D., Assistant Professor of Biomedical Engineering at Stony Brook University, is a 2010 recipient of the National Institutes of Health (NIH) Director's New Innovator Award.

14 Oct 2010

Researchers propose Nintendo Wii gaming to control gestational diabetes in women

Many women have trouble finding time to exercise in their busy lifestyles. That's especially true for pregnant women who live in northern climates such as Canada, where the weather can limit outdoor activity during winter months every year. But exercise is critical to managing gestational diabetes, a growing problem that occurs in 2 to 9 per cent of pregnancies.

14 Oct 2010

Agfa HealthCare to install first DX-D 500n direct radiography system in Canada at Sunnybrook Health Sciences Centre

Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, announces today that it will be installing its DX-D 500n Direct Radiography X-Ray Suite at Sunnybrook Health Sciences Centre in Toronto, Canada. Building upon Agfa HealthCare's expertise and history in imaging, the DX-D 500n completes Agfa HealthCare's digital imaging portfolio.

13 Oct 2010

Food allergies are becoming more common in U.S. children

The scary reality is that food allergies are becoming more and more common in the United States. In the last 10 years there has been an 18 percent increase in children with food allergies. In fact, one in 22 children has a food allergy. That means most likely there is at least one child in each classroom with a food allergy. Halloween parties and trick or treating are just a few of the end of fall activities that can heighten the danger for kids with food allergies.

13 Oct 2010

Study finds increase in hospitalizations for children due to ATV-related injuries

All-Terrain Vehicles (ATVs) are associated with a significant and increasing number of hospitalizations for children in the U.S., according to a new report by the Center for Injury Research and Policy at the Johns Hopkins Bloomberg School of Public Health. Over a nine- year period (1997-2006) hospitalizations for ATV injuries increased 150 percent among youth younger than 18 years, with important demographic variations.

13 Oct 2010

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

From Baxter International Inc. 13 Oct 2010

New 2010 clinical practice guidelines for diagnosis and management of osteoporosis in Canada released

Today, Osteoporosis Canada released its 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada, published in the Canadian Medical Association Journal. The new guidelines represent a paradigm shift in the prevention and treatment of osteoporotic fractures, moving the focus from treating low bone mineral density (BMD) to better identifying fractures caused by weakened bones (fragility fractures).

12 Oct 2010

Helmets to prevent rising off-road bike crashes

According to a new study Australia's off-road motorbike riders need to wear helmets more often. Research has shown that off-road crashes resulting in death or serious injury was the only rising category among Victoria's motorcycle community from 2001 to 2008. The results showed that the death toll from all motorcycle crashes plateaued over the period and this masked an almost doubling of the death and injuries which occurred off-road.

12 Oct 2010

Apollo completes first clinical case with FlexShears Endoscopic device

Apollo Endosurgery, Inc. announced completion of the first clinical case involving its FlexShears Endoscopic Scissors. The new device was used to cut and remove an obstructing eroded suture from the patient's GI tract in a procedure that embodies the Apollo vision of improving patient care with flexible surgery.

12 Oct 2010

Geron commences GRNOPC1 hESC-based cell therapy in patients with spinal cord injury

Geron Corporation today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1. The primary objective of this Phase I study is to assess the safety and tolerability of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) Impairment Scale grade A thoracic spinal cord injuries. Participants in the study must be newly injured and receive GRNOPC1 within 14 days of the injury.

11 Oct 2010

Researchers determine genetic structures of bacteria that cause Lyme disease

Researchers Dr. Steven E. Schutzer of UMDNJ-New Jersey Medical School and Dr. Claire M. Fraser-Liggett of the Institute for Genome Sciences, University of Maryland, and their collaborators have made a major achievement toward better understanding Lyme disease, by determining the complete genetic structures of 13 strains of the bacteria that cause the disease.

11 Oct 2010

Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies

BioTime, Inc. Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure will receive an equity investment of $7.1 million from BioTime, Teva Pharmaceutical Industries Ltd., and Hadasit Bio-Holdings (HBL).

11 Oct 2010

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).

11 Oct 2010

People involved in ATV crashes are more likely to die from serious trauma: Research

In research that may surprise off-road riding enthusiasts and safety experts, a Johns Hopkins team has found that crashes involving ATVs four-wheeled all-terrain vehicles — are significantly more dangerous than crashes involving two-wheeled off-road motorcycles, such as those used in extreme sports like Motocross.

8 Oct 2010

Trauma News and Research

DFG to establish new Research Units

Prolong Pharmaceuticals receives $30 million from private investor group

Allure Medical Spa to offer FDA approved Coolsculpting by Zeltiq for non-invasive fat reduction

GSA and NAM select journalists for new MetLife Foundation Journalists in Aging Fellows Program

U.S. Bone and Joint Decade observes National Action Week

Study finds hemostatic powder effective in treating 95% of patients with bleeding peptic ulcers

Stony Brook professor receives 2010 NIH Director's New Innovator Award

Researchers propose Nintendo Wii gaming to control gestational diabetes in women

Agfa HealthCare to install first DX-D 500n direct radiography system in Canada at Sunnybrook Health Sciences Centre

Food allergies are becoming more common in U.S. children

Study finds increase in hospitalizations for children due to ATV-related injuries

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

New 2010 clinical practice guidelines for diagnosis and management of osteoporosis in Canada released

Helmets to prevent rising off-road bike crashes

Apollo completes first clinical case with FlexShears Endoscopic device

Geron commences GRNOPC1 hESC-based cell therapy in patients with spinal cord injury

Researchers determine genetic structures of bacteria that cause Lyme disease

Cell Cure to receive equity investment of $7.1 million to develop stem cell-based therapies

Cell Cure, Teva Pharmaceutical enter license option agreement for OpRegen product

People involved in ATV crashes are more likely to die from serious trauma: Research

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News